Cargando…
Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
Autores principales: | Zhang, Ali, Breznik, Jessica A., Clare, Rumi, Nazy, Ishac, Miller, Matthew S., Bowdish, Dawn M.E., Costa, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AMDA - The Society for Post-Acute and Long-Term Care Medicine.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760605/ https://www.ncbi.nlm.nih.gov/pubmed/35041829 http://dx.doi.org/10.1016/j.jamda.2021.12.035 |
Ejemplares similares
-
Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents
por: Breznik, Jessica A., et al.
Publicado: (2021) -
Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study
por: Leong, Darryl P., et al.
Publicado: (2023) -
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities
por: Breznik, Jessica A., et al.
Publicado: (2023) -
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada
por: Breznik, Jessica A., et al.
Publicado: (2023) -
Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins
por: Sandoval, Carolyn, et al.
Publicado: (2004)